Prognostic values of negative estrogen or progesterone receptor expression in patients with luminal B HER2-negative breast cancer

BACKGROUND: The luminal subtype of breast cancer is sensitive to anti-estrogen therapy and shows a better prognosis than that of human epidermal growth factor receptor2 (HER2)-enriched or triple-negative breast cancer. However, the luminal type of breast cancer is heterogeneous and can have aggressi...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:World J Surg Oncol
Glavni autori: Park, Chansub, Park, Kyeongmee, Kim, Jiyoung, Sin, Youngjoo, Park, Inseok, Cho, Hyunjin, Yang, Keunho, Bae, Byung Noe, Kim, Ki Whan, Ahn, Sookyung, Gwak, Geumhee
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2016
Teme:
Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5020449/
https://ncbi.nlm.nih.gov/pubmed/27619909
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12957-016-0999-x
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items